Aclarubicin: preclinical and clinical data suggesting less chronic cardiotoxicity compared with conventional anthracyclines.
D015250:Aclarubicin; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D006321:Heart / Q000187:drug effects*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D009279:Naphthacenes / Q000009:adverse effects
D000903:Antibiotics, Antineoplastic; D009279:Naphthacenes; D015250:Aclarubicin